Most cited papers from PharmAccess Group

PharmAccess Group

What are the most cited papers from PharmAccess Group?

The most cited paper from PharmAccess Group is "Rising rural body-mass index is the main driver of the global obesity epidemic in adults" (Honor Bixby et al., 2019), with 758 citations. Next come "Best practices in scaling digital health in low and middle income countries" (477) and "Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis" (370).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 28 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Rising rural body-mass index is the main driver of the global obesity epidemic in adults Honor Bixby et al. · Nature Open access1,155 authors	8 May 2019	758
2	Best practices in scaling digital health in low and middle income countries Alain Bernard Labrique, Christina Wadhwani, Koku Awoonor Williams et al. · Globalization and Health Open access	3 Nov 2018	477
3	Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis Ravindra K. Gupta, Michael R. Jordan, Binta Sultan et al. · The Lancet Open access	22 Jul 2012	370
4	HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study Raph L Hamers, Carole L. Wallis, Cissy M Kityo et al. · The Lancet Infectious Diseases	29 Sep 2011	294
5	Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study Raph L Hamers, Rob Schuurman, Kim Sigaloff et al. · The Lancet Infectious Diseases	28 Oct 2011	197
6	Unnecessary Antiretroviral Treatment Switches and Accumulation of HIV Resistance Mutations; Two Arguments for Viral Load Monitoring in Africa Kim Sigaloff, Raph L Hamers, Carole L. Wallis et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes	21 Jun 2011	186
7	Patterns of HIV-1 Drug Resistance After First-Line Antiretroviral Therapy (ART) Failure in 6 Sub-Saharan African Countries: Implications for Second-Line ART Strategies Raph L Hamers, Kim Sigaloff, Annemarie M. J. Wensing et al. · Clinical Infectious Diseases Open access	3 Apr 2012	161
8	Association between health worker motivation and healthcare quality efforts in Ghana Robert Kaba Alhassan, Nicole Spieker, Paul Van Ostenberg et al. · Human Resources for Health Open access	14 Aug 2013	151
9	Infection prevention and control compliance in Tanzanian outpatient facilities: a cross-sectional study with implications for the control of COVID-19 Timothy Powell‐Jackson, Jessica King, Christina Makungu et al. · The Lancet Global Health Open access	6 May 2020	149
10	Comparison of Perceived and Technical Healthcare Quality in Primary Health Facilities: Implications for a Sustainable National Health Insurance Scheme in Ghana Robert Kaba Alhassan, Stephen Opoku Duku, Wendy Janssens et al. · PLoS ONE Open access	14 Oct 2015	114
11	HIV-1-resistance-associated mutations after failure of first-line antiretroviral treatment among children in resource-poor regions: a systematic review Kim Sigaloff, Job C. J. Calis, Sibyl P. M. Geelen et al. · The Lancet Infectious Diseases Review	27 Aug 2011	114
12	HIV-1 virologic failure and acquired drug resistance among first-line antiretroviral experienced adults at a rural HIV clinic in coastal Kenya: a cross-sectional study Amin S. Hassan, Helen Nabwera, Shalton M. Mwaringa et al. · AIDS Research and Therapy Open access	2014	105
13	Pharmacokinetic Properties of Mirabegron, a β3-Adrenoceptor Agonist: Results From Two Phase I, Randomized, Multiple-Dose Studies in Healthy Young and Elderly Men and Women Walter J. J. Krauwinkel, Jan A. G. M. van Dijk, Marloes P. Schaddelee et al. · Clinical Therapeutics	Oct 2012	98
14	Dried Fluid Spots for HIV Type-1 Viral Load and Resistance Genotyping: A Systematic Review Raph L Hamers, Pieter Willem Smit, Wendy Susan Stevens et al. · Antiviral Therapy Review	Jul 2009	82
15	Emerging HIV-1 drug resistance after roll-out of antiretroviral therapy in sub-Saharan Africa Raph L Hamers, Kim Sigaloff, Cissy M Kityo et al. · Current Opinion in HIV and AIDS	9 Nov 2012	79
16	Assessing the Impact of Community Engagement Interventions on Health Worker Motivation and Experiences with Clients in Primary Health Facilities in Ghana: A Randomized Cluster Trial Robert Kaba Alhassan, Edward Nketiah‐Amponsah, Nicole Spieker et al. · PLoS ONE Open access	20 Jul 2016	76
17	Implementation of an Antiretroviral Access Program for HIV-1-Infected Individuals in Resource-Limited Settings Papa Salif Sow, Leander F Otieno, E. Bissagnené et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes	15 Dec 2006	70
18	Second-Line Antiretroviral Treatment Successfully Resuppresses Drug-Resistant HIV-1 After First-Line Failure: Prospective Cohort in Sub-Saharan Africa Kim Sigaloff, Raph L Hamers, Carole L. Wallis et al. · The Journal of Infectious Diseases	23 Mar 2012	69
19	Transmitted antiretroviral drug resistance among newly HIV-1 diagnosed young individuals in Kampala Nicaise Ndembi, Raph L Hamers, Kim Sigaloff et al. · AIDS	17 Mar 2011	65
20	Accumulation of HIV Drug Resistance Mutations in Patients Failing First-Line Antiretroviral Treatment in South Africa Kim Sigaloff, Tina Ramatsebe, Raquel Pricilla e Silva Viana et al. · AIDS Research and Human Retroviruses	5 Aug 2011	65
21	Frugal innovation and sustainability outcomes: findings from a systematic literature review Valentina De Marchi, María Alejandra Pineda-Escobar, Rachel Howell et al. · European Journal of Innovation Management ReviewOpen access	16 Sep 2022	63
22	HIV–HBV Coinfection in Southern Africa and the Effect of Lamivudine- Versus Tenofovir-Containing cART on HBV Outcomes Raph L Hamers, Hans L. Zaaijer, Carole L. Wallis et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes	27 Jul 2013	63
23	Cohort Profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) Monitoring Studies to Evaluate Resistance—HIV drug resistance in sub-Saharan Africa and the Asia-Pacific Raph L Hamers et al. · International Journal of Epidemiology Open access	10 Nov 2010	62
24	Health insurance, a friend in need? Impacts of formal insurance and crowding out of informal insurance Xin Geng, Wendy Janssens, Berber Kramer et al. · World Development Open access	31 Jul 2018	61
25	Affordable in-house antiretroviral drug resistance assay with good performance in non-subtype B HIV-1 Carole L. Wallis, Maria Antonia Papathanasopoulos, Shabir Lakhi et al. · Journal of Virological Methods Open access	16 Nov 2009	60
26	Effectiveness of highly active antiretroviral therapy administered by general practitioners in rural South Africa Roos E. Barth, Jan T. M. van der Meer, Andy I. M. Hoepelman et al. · European Journal of Clinical Microbiology & Infectious Diseases Open access	15 Jul 2008	54
27	The Financial Burden of Non-Communicable Chronic Diseases in Rural Nigeria: Wealth and Gender Heterogeneity in Health Care Utilization and Health Expenditures Wendy Janssens, Jann Fabian Michael Goedecke, Godelieve J. de Bree et al. · PLoS ONE Open access	10 Nov 2016	52
28	Cost-effectiveness of laboratory monitoring for management of HIV treatment in sub-Saharan Africa Raph L Hamers, Anthony W. Sawyer, Martin Tuohy et al. · AIDS	13 Jun 2012	52
29	Nevirapine Plasma Concentrations and Concomitant Use of Rifampin in Patients Coinfected with HIV-1 and Tuberculosis Reshma Saskia Autar, Ferdinand W N M Wit, Jongkol Sankote et al. · Antiviral Therapy	Nov 2005	51
30	Social capital and active membership in the Ghana National Health Insurance Scheme - a mixed method study Christine Fenenga, Edward Nketiah‐Amponsah, Alice Ogink et al. · International Journal for Equity in Health Open access	2 Nov 2015	50
31	Effect of Community Engagement Interventions on Patient Safety and Risk Reduction Efforts in Primary Health Facilities: Evidence from Ghana Robert Kaba Alhassan, Edward Nketiah‐Amponsah, Nicole Spieker et al. · PLoS ONE Open access	30 Nov 2015	47
32	The Status of HIV-1 Resistance to Antiretroviral drugs in Sub-Saharan Africa Raph L Hamers, Inge Derdelinckx, Michèle van Vugt et al. · Antiviral Therapy Open access	Jul 2008	47
33	Costs and Cost-Effectiveness of Hypertension Screening and Treatment in Adults with Hypertension in Rural Nigeria in the Context of a Health Insurance Program Nicole T. A. Rosendaal, Marleen Elisabeth Hendriks, Mark D. Verhagen et al. · PLoS ONE Open access	27 Jun 2016	44
34	Barriers to Initiation of Pediatric HIV Treatment in Uganda: A Mixed-Method Study Tamara Sonia Boender, Kim Sigaloff, Joshua Kayiwa et al. · AIDS Research and Treatment Open access	2012	43
35	Global threat from drug resistant HIV in sub-Saharan Africa Raph L Hamers, Cissy M Kityo, Joep M. A. Lange et al. · BMJ	18 Jun 2012	42
36	Short Communication: High Prevalence of Transmitted Antiretroviral Drug Resistance Among Newly HIV Type 1 Diagnosed Adults in Mombasa, Kenya Kim Sigaloff, Kishor N. Mandaliya, Raph L Hamers et al. · AIDS Research and Human Retroviruses	13 Dec 2011	42
37	HIV-1 Drug Resistance Mutations Are Present in Six Percent of Persons Initiating Antiretroviral Therapy in Lusaka, Zambia Raph L Hamers, Margaret Siwale, Carole L. Wallis et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes	26 Jun 2010	41
38	Historical epidemiology of hepatitis C virus in select countries—volume 4 Abderrahmane Maaroufi et al. · Journal of Viral Hepatitis Open access129 authors	Nov 2017	40
39	Implementation of an international standardized set of outcome indicators in pregnancy and childbirth in Kenya: Utilizing mobile technology to collect patient-reported outcomes Ishtar Al-Shammari, Lina Maria Lopez Roa, Rachel R. Yorlets et al. · PLoS ONE Open access	16 Oct 2019	40
40	Incidence of HIV in Windhoek, Namibia: Demographic and Socio-Economic Associations Marielle Aulagnier, Wendy Janssens, Ingrid de Beer et al. · PLoS ONE Open access	4 Oct 2011	40
41	Role of Cytochrome P450 Isoenzymes 3A and 2D6 in the In Vivo Metabolism of Mirabegron, a β3-Adrenoceptor Agonist Jennifer Jooha Lee, Selina Moy, John Meijer et al. · Clinical Drug Investigation	30 Apr 2013	40
42	Efficacy and safety of the six-dose regimen of artemether–lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in adolescents and adults: A pooled analysis of individual patient data from randomized clinical trials Edgar A. Mueller, Michèle van Vugt, Wilhelm Kirch et al. · Acta Tropica	15 Oct 2006	39
43	Perspectives of frontline health workers on Ghana’s National Health Insurance Scheme before and after community engagement interventions Robert Kaba Alhassan, Edward Nketiah‐Amponsah, Nicole Spieker et al. · BMC Health Services Research Open access	28 May 2016	38
44	Medicine Prices, Availability, and Affordability in Private Health Facilities in Low-Income Settlements in Nairobi County, Kenya Dennis S. B. Ongarora, Jamlick Karumbi, Warnyta Minnaard et al. · Pharmacy Open access	24 Apr 2019	37
45	Determinants and perception of health insurance participation among healthcare providers in Nigeria: A mixed-methods study Hezekiah Olayinka Shobiye, Ibironke Dada, Njide Ndili et al. · PLoS ONE Open access	4 Aug 2021	35
46	Where and how our brain represents the temporal structure of observed action Rajat Mani Thomas, Teresa De Sanctis, Valeria Gazzola et al. · NeuroImage Open access	28 Aug 2018	35
47	Computational models can predict response to HIV therapy without a genotype and may reduce treatment failure in different resource-limited settings A. D. Revell, D. Wang, Robin Wood et al. · Journal of Antimicrobial Chemotherapy Open access	13 Mar 2013	35
48	SafeCare: An Innovative Approach for Improving Quality Through Standards, Benchmarking, and Improvement in Low- and Middle-Income Countries Michael C. Johnson, Onno P. Schellekens, Jacqui Stewart et al. · The Joint Commission Journal on Quality and Patient Safety	Aug 2016	34
49	Nucleoside Reverse Transcriptase Inhibitor Resistance Mutations Associated with First-Line Stavudine-Containing Antiretroviral Therapy: Programmatic Implications for Countries Phasing Out Stavudine Michele W. Tang et al. · The Journal of Infectious Diseases Open access	18 May 2013	34
50	Analyzing data from the digital healthcare exchange platform for surveillance of antibiotic prescriptions in primary care in urban Kenya: A mixed-methods study Legese Alemayehu Mekuria, Tobias FR de Wit, Nicole Spieker et al. · PLoS ONE Open access	26 Sep 2019	33

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.